The Download: whole-body rejuvenation drugs and five things to know about AI
Quick Answer
David Sinclair is set to test whole-body rejuvenation drugs as part of the XPrize competition, aiming to revolutionize longevity treatments.
Quick Take
This initiative could lead to significant advancements in healthcare, allowing patients to rejuvenate their bodies through innovative therapies.
Key Points
- David Sinclair is a prominent longevity scientist focused on rejuvenation therapies.
- The XPrize competition aims to accelerate breakthroughs in health and longevity.
- Whole-body rejuvenation drugs could transform patient care and treatment options.
- Sinclair's work emphasizes the potential for significant advancements in aging research.
- The initiative highlights the intersection of technology and healthcare innovation.
Source Excerpt
Plus: OpenAI has confidentially filed for a US IPO.
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from MIT Technology Review
See more →
1w ago
FeaturedOriginal
The Download: OpenAI unveils GPT-Red and heat pumps rise in the US
AI Summary
OpenAI's new GPT-Red automates red-teaming safety evaluations for software, enhancing security against human attackers. Meanwhile, heat pump sales in the US have doubled over 15 years, outperforming natural gas furnaces by 32% in early 2026, despite the expiration of a key tax credit.
